VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $92,000 | +3.4% | 14,614 | -2.0% | 0.00% | 0.0% |
| Q2 2021 | $89,000 | -6.3% | 14,912 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $95,000 | +9.2% | 15,075 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $87,000 | -5.4% | 15,507 | -1.6% | 0.00% | -50.0% |
| Q3 2020 | $92,000 | -21.4% | 15,760 | -3.2% | 0.00% | 0.0% |
| Q2 2020 | $117,000 | +56.0% | 16,280 | +1.7% | 0.00% | 0.0% |
| Q1 2020 | $75,000 | -42.7% | 16,007 | -1.8% | 0.00% | -33.3% |
| Q4 2019 | $131,000 | +13.9% | 16,295 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $115,000 | -18.4% | 16,707 | -1.6% | 0.00% | 0.0% |
| Q2 2019 | $141,000 | -28.1% | 16,985 | -13.6% | 0.00% | -25.0% |
| Q1 2019 | $196,000 | -3.9% | 19,669 | -26.1% | 0.00% | -20.0% |
| Q4 2018 | $204,000 | – | 26,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |